Treatment of Epstein–Barr Virus Infections: Chemotherapy, Antiviral Therapy, and Immunotherapy

This publication has 113 references indexed in Scilit:

• 17. New Chemotherapeutic Agents, New Modalities
  Annals of Oncology, 2002
• Epstein–Barr virus post‐transplant lymphoproliferative disease and virus‐specific therapy: pharmacological re‐activation of viral target genes with arginine butyrate
  Transplant Infectious Disease, 2001
• Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma
  International Journal of Cancer, 2001
• Epstein–Barr Virus Infection
  New England Journal of Medicine, 2000
• Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations
  International Journal of Cancer, 1999
• Tumour surveillance: Missing peptides and MHC molecules
  Immunology & Cell Biology, 1998
• HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
  Annual Review of Immunology, 1997
• Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation
  New England Journal of Medicine, 1991
• Treatment of B-Cell Lymphoproliferative Disorders with Interferon Alfa and Intravenous Gamma Globulin
  New England Journal of Medicine, 1988
• Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal Transplantation
  New England Journal of Medicine, 1982